Advisory Services Network’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Advisory Services Network’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-20,328	Closed	-$410K	–	1541
2021 Q3	$410K	Sell	20,328 -2,140	-10%	-$59.1K	0.01%	957
2021 Q2	$839K	Sell	22,468 -266	-1%	-$8.15K	0.03%	665
2021 Q1	$581K	Buy	+22,734	New	+$581K	0.02%	785
2020 Q1	–	Sell	-3,348	Closed	-$74K	–	3396
2019 Q4	$74K	Buy	+3,348	New	+$67.4K	﹤0.01%	1307

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Advisory Services Network's DRNA Position: Q4 2021 in Review

Advisory Services Network sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 20,328 shares — an estimated $410K sold.

Advisory Services Network first reported a position in DRNA in Q4 2019 and held it in 4 quarters. The position peaked at $839K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Advisory Services Network reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Advisory Services Network sold 20,328 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $410K.
Advisory Services Network first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2019 and held it in 4 quarters.
Advisory Services Network's Dicerna Pharmaceuticals, Inc. position peaked at $839K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Advisory Services Network's 13F filing for Q4 2021, filed 14 Feb 2022.